WithdrawnNot Applicable

Effectiveness of Oral Albendazole in the Treatment of Severe Acute Malnutrition

Stopped: not funded

Malawi0Started 2013-01

Plain-language summary

The benefit of anti-worm therapy as part of the case management of severe acute malnutrition (SAM) in the outpatient setting has not previously been studied. This study will compare recovery rates of children with SAM treated in the community with locally-produced ready-to-use therapeutic food (RUTF) with and without prescribed albendazole as part of their case management.

Who can participate

Age range6 Months – 59 Months

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 12-59 months old * Kwashiorkor and/or Marasmus * Qualified for home-based therapeutic feeding with RUTF Exclusion Criteria: * Obvious congenital or other malformation that makes child a poor candidate for feeding with RUTF * Unable to consume test-dose of RUTF in clinic * Parent refusal to participate and return for follow-up

What they're measuring

nutritional recovery

Timeframe: 12 weeks

mortality

Timeframe: 12 weeks

Trial details

NCT IDNCT01395381

SponsorWashington University School of Medicine

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2014-01

View on ClinicalTrials.gov More Kwashiorkor trials